Reaction

Catheter Site Warmth reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 149 reports · 3 co-occurring drugs

As of the last recalculation, Catheter Site Warmth appears in 149 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 417.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Epoprostenol31417.5418.5
Macitentan41113.7113.8
Treprostinil4980.880.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.